 | • レポートコード：MRC23Q36055 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のヘリコバクターピロリ非侵襲的検査市場について調査・分析し、世界のヘリコバクターピロリ非侵襲的検査市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血清学的検査、尿素呼気検査（UBT）、便潜血検査（SAT））、用途別セグメント分析（病院、診療所、診断所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott、Sekisui Diagnostics、F. Hoffmann-La Roche、Medline Industries、Meridian Bioscience、Bio-Rad Laboratories、Thermo Fisher Scientific、Alpha Laboratories、EKF Diagnostics、Quidel、Halyard Health, Inc、Cardinal Health、Beckman Coulter Inc、Agilent Technologies、Coris BioConceptなどが含まれています。 世界のヘリコバクターピロリ非侵襲的検査市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ヘリコバクターピロリ非侵襲的検査市場規模を推定する際に考慮しました。本レポートは、ヘリコバクターピロリ非侵襲的検査の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ヘリコバクターピロリ非侵襲的検査に関するビジネス上の意思決定に役立てることを目的としています。 ・ヘリコバクターピロリ非侵襲的検査市場の概要 - ヘリコバクターピロリ非侵襲的検査のタイプ別セグメント - 世界のヘリコバクターピロリ非侵襲的検査市場規模：タイプ別分析（血清学的検査、尿素呼気検査（UBT）、便潜血検査（SAT）） - ヘリコバクターピロリ非侵襲的検査の用途別セグメント - 世界のヘリコバクターピロリ非侵襲的検査市場規模：用途別分析（病院、診療所、診断所、その他） - 世界のヘリコバクターピロリ非侵襲的検査市場規模予測（2018年-2029年） ・ヘリコバクターピロリ非侵襲的検査市場の成長トレンド - ヘリコバクターピロリ非侵襲的検査の地域別市場規模（2018年-2029年） - ヘリコバクターピロリ非侵襲的検査市場ダイナミクス - ヘリコバクターピロリ非侵襲的検査の業界動向 - ヘリコバクターピロリ非侵襲的検査市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：血清学的検査、尿素呼気検査（UBT）、便潜血検査（SAT） - 世界のヘリコバクターピロリ非侵襲的検査のタイプ別市場規模（2018年-2023年） - 世界のヘリコバクターピロリ非侵襲的検査のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所、診断所、その他 - 世界のヘリコバクターピロリ非侵襲的検査の用途別市場規模（2018年-2023年） - 世界のヘリコバクターピロリ非侵襲的検査の用途別市場規模（2024年-2029年） ・ヘリコバクターピロリ非侵襲的検査の地域別市場規模 - 北米のヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - アメリカのヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - ヨーロッパのヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - アジア太平洋のヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - 中国のヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - 日本のヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - 韓国のヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - インドのヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - オーストラリアのヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - 中南米のヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） - 中東・アフリカのヘリコバクターピロリ非侵襲的検査市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Abbott、Sekisui Diagnostics、F. Hoffmann-La Roche、Medline Industries、Meridian Bioscience、Bio-Rad Laboratories、Thermo Fisher Scientific、Alpha Laboratories、EKF Diagnostics、Quidel、Halyard Health, Inc、Cardinal Health、Beckman Coulter Inc、Agilent Technologies、Coris BioConcept ・アナリストの観点/結論 ・調査方法とデータソース |
Helicobacter pylori is a type of bacteria that is known to be a major cause of peptic ulcers, which are sores on the lining of the esophagus, stomach or small intestine. H. pylori testing detects an infection of the digestive tract caused by the bacteria to help diagnose the cause of symptoms and/or ulcers.
H. pylori infections of the digestive tract are very common, with as many as half of the world’s population infected. However, most people with H. pylori never have any symptoms. Still, H. pylori infection increases the risk of developing ulcers (peptic ulcer disease), persistent stomach inflammation (gastritis), and gastric (stomach) cancer. The bacteria decrease the stomach’s ability to produce mucus, making the stomach prone to damage from digestive acid and peptic ulcers.
Highlights
The global Helicobacter Pylori Non-Invasive Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Helicobacter Pylori Non-Invasive Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Helicobacter Pylori Non-Invasive Testing include Abbott, Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories and EKF Diagnostics, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Non-Invasive Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Non-Invasive Testing.
The Helicobacter Pylori Non-Invasive Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Helicobacter Pylori Non-Invasive Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Helicobacter Pylori Non-Invasive Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health, Inc
Cardinal Health
Beckman Coulter Inc
Agilent Technologies
Coris BioConcept
Segment by Type
Serologic Test
Urea Breath Test (UBT)
Stool Antigen Test (SAT)
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Non-Invasive Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helicobacter Pylori Non-Invasive Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Serologic Test
1.2.3 Urea Breath Test (UBT)
1.2.4 Stool Antigen Test (SAT)
1.3 Market by Application
1.3.1 Global Helicobacter Pylori Non-Invasive Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Helicobacter Pylori Non-Invasive Testing Market Perspective (2018-2029)
2.2 Helicobacter Pylori Non-Invasive Testing Growth Trends by Region
2.2.1 Global Helicobacter Pylori Non-Invasive Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Helicobacter Pylori Non-Invasive Testing Historic Market Size by Region (2018-2023)
2.2.3 Helicobacter Pylori Non-Invasive Testing Forecasted Market Size by Region (2024-2029)
2.3 Helicobacter Pylori Non-Invasive Testing Market Dynamics
2.3.1 Helicobacter Pylori Non-Invasive Testing Industry Trends
2.3.2 Helicobacter Pylori Non-Invasive Testing Market Drivers
2.3.3 Helicobacter Pylori Non-Invasive Testing Market Challenges
2.3.4 Helicobacter Pylori Non-Invasive Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Helicobacter Pylori Non-Invasive Testing Players by Revenue
3.1.1 Global Top Helicobacter Pylori Non-Invasive Testing Players by Revenue (2018-2023)
3.1.2 Global Helicobacter Pylori Non-Invasive Testing Revenue Market Share by Players (2018-2023)
3.2 Global Helicobacter Pylori Non-Invasive Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Helicobacter Pylori Non-Invasive Testing Revenue
3.4 Global Helicobacter Pylori Non-Invasive Testing Market Concentration Ratio
3.4.1 Global Helicobacter Pylori Non-Invasive Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helicobacter Pylori Non-Invasive Testing Revenue in 2022
3.5 Helicobacter Pylori Non-Invasive Testing Key Players Head office and Area Served
3.6 Key Players Helicobacter Pylori Non-Invasive Testing Product Solution and Service
3.7 Date of Enter into Helicobacter Pylori Non-Invasive Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Helicobacter Pylori Non-Invasive Testing Breakdown Data by Type
4.1 Global Helicobacter Pylori Non-Invasive Testing Historic Market Size by Type (2018-2023)
4.2 Global Helicobacter Pylori Non-Invasive Testing Forecasted Market Size by Type (2024-2029)
5 Helicobacter Pylori Non-Invasive Testing Breakdown Data by Application
5.1 Global Helicobacter Pylori Non-Invasive Testing Historic Market Size by Application (2018-2023)
5.2 Global Helicobacter Pylori Non-Invasive Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Helicobacter Pylori Non-Invasive Testing Market Size (2018-2029)
6.2 North America Helicobacter Pylori Non-Invasive Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Helicobacter Pylori Non-Invasive Testing Market Size by Country (2018-2023)
6.4 North America Helicobacter Pylori Non-Invasive Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Helicobacter Pylori Non-Invasive Testing Market Size (2018-2029)
7.2 Europe Helicobacter Pylori Non-Invasive Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Helicobacter Pylori Non-Invasive Testing Market Size by Country (2018-2023)
7.4 Europe Helicobacter Pylori Non-Invasive Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market Size (2018-2029)
8.2 Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Helicobacter Pylori Non-Invasive Testing Market Size (2018-2029)
9.2 Latin America Helicobacter Pylori Non-Invasive Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Helicobacter Pylori Non-Invasive Testing Market Size by Country (2018-2023)
9.4 Latin America Helicobacter Pylori Non-Invasive Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Helicobacter Pylori Non-Invasive Testing Market Size (2018-2029)
10.2 Middle East & Africa Helicobacter Pylori Non-Invasive Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Helicobacter Pylori Non-Invasive Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Helicobacter Pylori Non-Invasive Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Helicobacter Pylori Non-Invasive Testing Introduction
11.1.4 Abbott Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Sekisui Diagnostics
11.2.1 Sekisui Diagnostics Company Detail
11.2.2 Sekisui Diagnostics Business Overview
11.2.3 Sekisui Diagnostics Helicobacter Pylori Non-Invasive Testing Introduction
11.2.4 Sekisui Diagnostics Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.2.5 Sekisui Diagnostics Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Helicobacter Pylori Non-Invasive Testing Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Medline Industries
11.4.1 Medline Industries Company Detail
11.4.2 Medline Industries Business Overview
11.4.3 Medline Industries Helicobacter Pylori Non-Invasive Testing Introduction
11.4.4 Medline Industries Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.4.5 Medline Industries Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Detail
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Helicobacter Pylori Non-Invasive Testing Introduction
11.5.4 Meridian Bioscience Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.5.5 Meridian Bioscience Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Helicobacter Pylori Non-Invasive Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Helicobacter Pylori Non-Invasive Testing Introduction
11.7.4 Thermo Fisher Scientific Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Alpha Laboratories
11.8.1 Alpha Laboratories Company Detail
11.8.2 Alpha Laboratories Business Overview
11.8.3 Alpha Laboratories Helicobacter Pylori Non-Invasive Testing Introduction
11.8.4 Alpha Laboratories Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.8.5 Alpha Laboratories Recent Development
11.9 EKF Diagnostics
11.9.1 EKF Diagnostics Company Detail
11.9.2 EKF Diagnostics Business Overview
11.9.3 EKF Diagnostics Helicobacter Pylori Non-Invasive Testing Introduction
11.9.4 EKF Diagnostics Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.9.5 EKF Diagnostics Recent Development
11.10 Quidel
11.10.1 Quidel Company Detail
11.10.2 Quidel Business Overview
11.10.3 Quidel Helicobacter Pylori Non-Invasive Testing Introduction
11.10.4 Quidel Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.10.5 Quidel Recent Development
11.11 Halyard Health, Inc
11.11.1 Halyard Health, Inc Company Detail
11.11.2 Halyard Health, Inc Business Overview
11.11.3 Halyard Health, Inc Helicobacter Pylori Non-Invasive Testing Introduction
11.11.4 Halyard Health, Inc Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.11.5 Halyard Health, Inc Recent Development
11.12 Cardinal Health
11.12.1 Cardinal Health Company Detail
11.12.2 Cardinal Health Business Overview
11.12.3 Cardinal Health Helicobacter Pylori Non-Invasive Testing Introduction
11.12.4 Cardinal Health Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.12.5 Cardinal Health Recent Development
11.13 Beckman Coulter Inc
11.13.1 Beckman Coulter Inc Company Detail
11.13.2 Beckman Coulter Inc Business Overview
11.13.3 Beckman Coulter Inc Helicobacter Pylori Non-Invasive Testing Introduction
11.13.4 Beckman Coulter Inc Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.13.5 Beckman Coulter Inc Recent Development
11.14 Agilent Technologies
11.14.1 Agilent Technologies Company Detail
11.14.2 Agilent Technologies Business Overview
11.14.3 Agilent Technologies Helicobacter Pylori Non-Invasive Testing Introduction
11.14.4 Agilent Technologies Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.14.5 Agilent Technologies Recent Development
11.15 Coris BioConcept
11.15.1 Coris BioConcept Company Detail
11.15.2 Coris BioConcept Business Overview
11.15.3 Coris BioConcept Helicobacter Pylori Non-Invasive Testing Introduction
11.15.4 Coris BioConcept Revenue in Helicobacter Pylori Non-Invasive Testing Business (2018-2023)
11.15.5 Coris BioConcept Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details